Gillatt, John
34  results:
Search for persons X
?
1

Patient-Reported Outcomes 12 Years after Localized Prostate..:

Donovan, Jenny L ; Hamdy, Freddie C ; Lane, J. Athene...
Donovan , J L , Hamdy , F C , Lane , J A , Young , G , Metcalfe , C , Walsh , E I , Davis , M J , Steuart-Feilding , T A H M , Blazeby , J , Avery , K N L , Martin , R M , Bollina , P , Doble , A , Doherty , A , Gillatt , D A , Gnanapragasam , V , Hughes , O , Kockelbergh , R , Kynaston , H , Paul , A , Paez , E , Powell , P , Rosario , D , Rowe , E , Mason , M , Catto , J , Peters , TJ , Wade , J , Turner , E L , Williams , N J , Oxley , J , Staffurth , J , Bryant , R J & Neal , D E 2023 , ' Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment ' , NEJM Evidence , vol. 2 , no. 3 . https://doi.org/10.1056/EVIDoa2300018.  , 2023
 
?
3

Functional and quality of life outcomes of localised prosta..:

Lane, J. Athene ; Donovan, Jenny L ; Young, Grace...
Lane , J A , Donovan , J L , Young , G , Davis , M J , Walsh , E I , Avery , K N L , Blazeby , J , Mason , M , Martin , R M , Peters , TJ , Turner , E L , Wade , J , Bollina , P , Catto , J , Doherty , A , Gillatt , D , Gnanapragasam , V , Hughes , O , Kockelbergh , R , Kynaston , H , Oxley , J , Paul , A , Paez , E , Rosario , D J , Rowe , E , Staffurth , J , Neal , D , Hamdy , F C & Metcalfe , C 2022 , ' Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study) ' , BJU International , vol. 130 , no. 3 , pp. 370-380 . https://doi.org/10.1111/bju.15739.  , 2022
 
?
5

High-dose vitamin D supplementation to prevent prostate can..:

Nair-Shalliker, Visalini ; Smith, David P ; Gebski, Val...
Nair-Shalliker , V , Smith , D P , Gebski , V , Patel , M I , Frydenberg , M , Yaxley , J W , Gardiner , R , Espinoza , D , Kimlin , M G , Fenech , M , Gillatt , D , Woo , H , Armstrong , B K , Rasiah , K , Awad , N , Symons , J & Gurney , H 2021 , ' High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD) : protocol of a phase II randomised controlled trial ' , BMJ Open , vol. 11 , no. 3 , e044055 , pp. 1-9 . https://doi.org/10.1136/bmjopen-2020-044055.  , 2021
 
?
 
?
11

Active monitoring, radical prostatectomy and radical radiot..:

Hamdy, Freddie C ; Donovan, Jenny L ; Lane, J Athene...
Hamdy , F C , Donovan , J L , Lane , J A , Mason , M , Metcalfe , C , Holding , P , Wade , J , Noble , S , Garfield , K , Young , G , Davis , M , Peters , T J , Turner , E L , Martin , R M , Oxley , J , Robinson , M , Staffurth , J , Walsh , E , Blazeby , J , Bryant , R , Bollina , P , Catto , J , Doble , A , Doherty , A , Gillatt , D , Gnanapragasam , V , Hughes , O , Kockelbergh , R , Kynaston , H , Paul , A , Paez , E , Powell , P , Prescott , S , Rosario , D , Rowe , E & Neal , D 2020 , ' Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer : the ProtecT three-arm RCT ' , Health Technology Assessment , vol. 24 , no. 37 , pp. 1-176 . https://doi.org/10.3310/hta24370.  , 2020
 
?
13

Ten-year mortality, disease progression and treatment-relat..:

Neal, David E ; Metcalfe, Chris ; Donovan, Jenny L...
Neal , D E , Metcalfe , C , Donovan , J L , Lane , J A , Davis , M J , Young , G J , Dutton , S J , Walsh , E I , Martin , R M , Peters , T J , Turner , E L , Mason , M , Bollina , P , Catto , J , Doherty , A , Gillatt , D , Gnanapragasam , V , Holding , P , Hughes , O , Kockelbergh , R , Kynaston , H , Oxley , J , Paul , A , Paez , E , Rosario , D J , Rowe , E , Staffurth , J , Altman , D G & Hamdy , F C 2020 , ' Ten-year mortality, disease progression and treatment-related side-effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received ' , European Urology , vol. 77 , no. 3 , pp. 320-330 . https://doi.org/10.1016/j.eururo.2019.10.030.  , 2020
 
?
14

The ProtecT trial:analysis of the patient cohort, baseline ..:

Bryant, Richard J ; Oxley, Jon ; Young, Grace J...
Bryant , R J , Oxley , J , Young , G J , Lane , J A , Metcalfe , C , Davis , M , Turner , E L , Martin , R M , Goepel , J R , Varma , M , Griffiths , D F , Grigor , K , Mayer , N , Warren , A Y , Bhattarai , S , Dormer , J , Mason , M , Staffurth , J , Walsh , E , Rosario , D J , F Catto , J W , Neal , D E , Donovan , J L , Hamdy , F C , Bollina , P , Doble , A , Doherty , A , Gillatt , D , Gnanapragasam , V , Hughes , O , Kockelbergh , R , Kynaston , H , Paul , A , Paez , E , Rowe , E & the ProtecT Study Group 2020 , ' The ProtecT trial : analysis of the patient cohort, baseline risk stratification and disease progression ' , BJU International . https://doi.org/10.1111/bju.14987.  , 2020
 
1-15